BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25202094)

  • 1. Radiosurgery alone for 1-3 newly-diagnosed brain metastases from melanoma: impact of dose on treatment outcomes.
    Rades D; Sehmisch L; Huttenlocher S; Blank O; Hornung D; Terheyden P; Gliemroth J; Schild SE
    Anticancer Res; 2014 Sep; 34(9):5079-82. PubMed ID: 25202094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two dose levels of stereotactic radiosurgery for 1-3 brain metastases from non-small cell lung cancer.
    Rades D; Huttenlocher S; Dahlke M; Hornung D; Blanck O; Van Thai P; Trang NT; Khoa MT; Schild SE
    Anticancer Res; 2014 Dec; 34(12):7309-13. PubMed ID: 25503165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases.
    Selek U; Chang EL; Hassenbusch SJ; Shiu AS; Lang FF; Allen P; Weinberg J; Sawaya R; Maor MH
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1097-106. PubMed ID: 15234044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome variation among "radioresistant" brain metastases treated with stereotactic radiosurgery.
    Chang EL; Selek U; Hassenbusch SJ; Maor MH; Allen PK; Mahajan A; Sawaya R; Woo SY
    Neurosurgery; 2005 May; 56(5):936-45; discussion 936-45. PubMed ID: 15854241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linear accelerator based stereotactic radiosurgery for melanoma brain metastases.
    Bernard ME; Wegner RE; Reineman K; Heron DE; Kirkwood J; Burton SA; Mintz AH
    J Cancer Res Ther; 2012; 8(2):215-21. PubMed ID: 22842364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic radiosurgery for newly diagnosed brain metastases: comparison of three dose levels.
    Rades D; Hornung D; Blanck O; Martens K; Khoa MT; Trang NT; Hüppe M; Terheyden P; Gliemroth J; Schild SE
    Strahlenther Onkol; 2014 Sep; 190(9):786-91. PubMed ID: 24663288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases.
    Varlotto JM; Flickinger JC; Niranjan A; Bhatnagar A; Kondziolka D; Lunsford LD
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1125-32. PubMed ID: 15990018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of stereotactic radiosurgery dose on control of cerebral metastases from renal cell carcinoma.
    Rades D; Huttenlocher S; Gebauer N; Hornung D; Trang NT; Khoa MT; Schild SE
    Anticancer Res; 2015 Jun; 35(6):3571-4. PubMed ID: 26026128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
    Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases.
    Rades D; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
    Cancer; 2007 Nov; 110(10):2285-92. PubMed ID: 17922523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyberknife for brain metastases of malignant melanoma and renal cell carcinoma.
    Hara W; Tran P; Li G; Su Z; Puataweepong P; Adler JR; Soltys SG; Chang SD; Gibbs IC
    Neurosurgery; 2009 Feb; 64(2 Suppl):A26-32. PubMed ID: 19165071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying melanoma patients with 1-3 brain metastases who may benefit from whole-brain irradiation in addition to radiosurgery.
    Huttenlocher S; Sehmisch L; Schild SE; Blank O; Hornung D; Rades D
    Anticancer Res; 2014 Oct; 34(10):5589-92. PubMed ID: 25275060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic radiosurgery plus whole-brain radiotherapy for treatment of multiple metastases from non-small cell lung cancer.
    Minniti G; Salvati M; Muni R; Lanzetta G; Osti MF; Clarke E; Costa A; Bozzao A; Trasimeni G; Enrici RM
    Anticancer Res; 2010 Jul; 30(7):3055-61. PubMed ID: 20683055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reirradiation of brain metastases with radiosurgery.
    Maranzano E; Trippa F; Casale M; Costantini S; Anselmo P; Carletti S; Principi M; Caserta C; Loreti F; Giorgi C
    Radiother Oncol; 2012 Feb; 102(2):192-7. PubMed ID: 21880387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS).
    Samlowski WE; Watson GA; Wang M; Rao G; Klimo P; Boucher K; Shrieve DC; Jensen RL
    Cancer; 2007 May; 109(9):1855-62. PubMed ID: 17351953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining the Optimal Dose of Stereotactic Radiosurgery for Treating Cerebral Metastases in Elderly Patients.
    Rades D; Dahlke M; Dziggel L; Janssen S; Bajrovic A; Trang NT; Khoa MT; Schild SE
    Anticancer Res; 2015 Oct; 35(10):5701-4. PubMed ID: 26408746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between volume, dose and local control in stereotactic radiosurgery of brain metastasis.
    Molenaar R; Wiggenraad R; Verbeek-de Kanter A; Walchenbach R; Vecht C
    Br J Neurosurg; 2009 Apr; 23(2):170-8. PubMed ID: 19306173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma knife radiosurgery in the management of malignant melanoma brain metastases.
    Mathieu D; Kondziolka D; Cooper PB; Flickinger JC; Niranjan A; Agarwala S; Kirkwood J; Lunsford LD
    Neurosurgery; 2007 Mar; 60(3):471-81; discussion 481-2. PubMed ID: 17327791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome after radiosurgery for brain metastases in patients with low Karnofsky performance scale (KPS) scores.
    Chernov MF; Nakaya K; Izawa M; Hayashi M; Usuba Y; Kato K; Muragaki Y; Iseki H; Hori T; Takakura K
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1492-8. PubMed ID: 17276617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.